FRPP, a government/pharmacy partnership, delivered 67.7% of the 59.8 million COVID-19 vaccines administered in the US from September 2022 through September 2023. Access to bivalent COVID-19 ...

Tarlatamab is an investigational first-in-class, bispecific T-cell engager immunotherapy designed to target delta-like ligand 3 on small cell lung cancer (SCLC) cells and CD3 on T cells. The ...

Dark-Room Prone Testing can help predict the risk of superior visual field defect progression in patients with glaucoma. Intraocular pressure (IOP) after dark-room prone testing (DRPT) and IOP change ...

Globular or exophytic growth pattern in optic nerve meningioma can be treated surgically in some patients. Surgical management can relieve mass effect symptoms from intraorbital exophytic or globular ...

Corneal tomography risk factors and changes can help predict acute corneal hydrops. Steep keratometry, thin corneas, and Down syndrome are risk factors for developing acute corneal hydrops (ACH), ...

Patients with idiopathic intracranial hypertension may require additional in-office education. Idiopathic intracranial hypertension online information directed at patients tends to be of ...

Credit: Getty Images A team of ophthalmologists with the University of Nebraska Medical Center reviewed the research revealing how a multidisciplinary approach to care can benefit patients with ...

A COVID-19 infection does not permanently change the radial peripapillary capillary or RNFL optic disc parameters. Radial peripapillary capillary (RPC) and retinal nerve fiber layer (RNFL) optic disc ...

An aflibercept biosimilar (P041) has equivalent efficacy and safety as originator aflibercept (AFL) for neovascular age-related macular degeneration (nAMD) treatment, according to study results ...

A team of ophthalmologists with the University of Nebraska Medical Center reviewed the research revealing how a multidisciplinary approach to care can benefit patients with uveitis and ease the burden ...